Literature DB >> 18084948

Second-line chemotherapy in advanced pancreatic cancer.

U Pelzer1.   

Abstract

This chapter focuses on second-line therapy in inoperable pancreatic cancer.

Entities:  

Mesh：

Year:  2008        PMID： 18084948     DOI： 10.1007/978-3-540-71279-4_8

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN： 0080-0015


  2 in total

1.  Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study.

Authors:  Uwe Pelzer; Dirk Arnold; Mehmet Gövercin; Jens Stieler; Bernd Doerken; Hanno Riess; Helmut Oettle
Journal:  BMC Cancer       Date:  2010-03-09       Impact factor: 4.430

2.  Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy.

Authors:  Uwe Pelzer; Andreas Hilbig; Marianne Sinn; Jens Stieler; Marcus Bahra; Bernd Dörken; Hanno Riess
Journal:  Front Oncol       Date:  2013-06-14       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.